ClearPoint Neuro/$CLPT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ClearPoint Neuro
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
Ticker
$CLPT
Sector
Primary listing
Employees
115
Headquarters
Website
ClearPoint Neuro Metrics
BasicAdvanced
$721M
-
-$0.80
0.85
-
Price and volume
Market cap
$721M
Beta
0.85
52-week high
$30.10
52-week low
$9.76
Average daily volume
1.3M
Financial strength
Current ratio
7.298
Quick ratio
6.191
Long term debt to equity
177.911
Total debt to equity
179.588
Profitability
EBITDA (TTM)
-21.645
Gross margin (TTM)
60.42%
Net profit margin (TTM)
-66.15%
Operating margin (TTM)
-67.42%
Effective tax rate (TTM)
-0.06%
Revenue per employee (TTM)
$290,000
Management effectiveness
Return on assets (TTM)
-24.52%
Return on equity (TTM)
-85.68%
Valuation
Price to revenue (TTM)
20.994
Price to book
36.53
Price to tangible book (TTM)
36.53
Price to free cash flow (TTM)
-60.2
Free cash flow yield (TTM)
-1.66%
Free cash flow per share (TTM)
-0.422
Growth
Revenue change (TTM)
19.68%
Earnings per share change (TTM)
13.58%
3-year revenue growth (CAGR)
20.74%
10-year revenue growth (CAGR)
25.63%
3-year earnings per share growth (CAGR)
3.24%
10-year earnings per share growth (CAGR)
-21.12%
What the Analysts think about ClearPoint Neuro
Analyst ratings (Buy, Hold, Sell) for ClearPoint Neuro stock.
ClearPoint Neuro Financial Performance
Revenues and expenses
ClearPoint Neuro Earnings Performance
Company profitability
ClearPoint Neuro News
AllArticlesVideos
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
Accesswire2 weeks ago
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
Accesswire2 weeks ago
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
Accesswire3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ClearPoint Neuro stock?
ClearPoint Neuro (CLPT) has a market cap of $721M as of October 19, 2025.
What is the P/E ratio for ClearPoint Neuro stock?
The price to earnings (P/E) ratio for ClearPoint Neuro (CLPT) stock is 0 as of October 19, 2025.
Does ClearPoint Neuro stock pay dividends?
No, ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders as of October 19, 2025.
When is the next ClearPoint Neuro dividend payment date?
ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders.
What is the beta indicator for ClearPoint Neuro?
ClearPoint Neuro (CLPT) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.